Recursion Pharmaceuticals (RXRX) Operating Leases (2022 - 2026)
Recursion Pharmaceuticals (RXRX) posted Operating Leases of $39.19 million for Q2 2026, down 26.6% from $53.4 million a year earlier and down 8.5% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Recursion Pharmaceuticals' Operating Leases came in at $46.65 million, down 30.6% from FY2024.
- Annual Operating Leases shows a three-year compound annual growth rate of 1.6% (FY2022 to FY2025).
- In prior years, Recursion Pharmaceuticals' Operating Leases was $67.25 million in FY2024 (+54.9%), $43.41 million in FY2023 (-2.3%) and $44.42 million in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Operating Leases in data going back to Q1 2022.
- On a year-over-year basis, Operating Leases has declined in each of the last four quarters, with growth averaging 2.8% over the last eight quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q4 2024, with growth of 54.9%; the weakest was Q4 2025, with a decline of 30.6%.
- According to Business Quant data, Operating Leases for the three prior quarters was $42.84 million (Q1 2026), $46.65 million (Q4 2025) and $50.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.19 Mn |
| Mar 31, 2026 | 42.84 Mn |
| Dec 31, 2025 | 46.65 Mn |
| Sep 30, 2025 | 50.03 Mn |
| Jun 30, 2025 | 53.40 Mn |
| Mar 31, 2025 | 56.02 Mn |
| Dec 31, 2024 | 67.25 Mn |
| Sep 30, 2024 | 53.66 Mn |
| Jun 30, 2024 | 50.24 Mn |
| Mar 31, 2024 | 43.79 Mn |
| Dec 31, 2023 | 43.41 Mn |
| Sep 30, 2023 | 44.30 Mn |
| Jun 30, 2023 | 45.85 Mn |
| Mar 31, 2023 | 46.77 Mn |
| Dec 31, 2022 | 44.42 Mn |
| Sep 30, 2022 | 45.99 Mn |
| Jun 30, 2022 | 47.76 Mn |
| Mar 31, 2022 | 47.32 Mn |
API Access
Recursion Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();